about
Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy.Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemiaPathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.Microparticles in tumor progression.Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase.Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.Structural Insights into the ATP Binding Pocket of the Anaplastic Lymphoma Kinase by Site-Directed Mutagenesis, Inhibitor Binding Analysis, and Homology Modeling
P50
Q36158713-6AA28F9D-5442-4D03-BF7E-86082144D12DQ37625070-5E9FBE06-D00A-4F99-B520-CAE42000CB0CQ37973346-C163B1A6-B5D7-4B57-8E9C-927807D8238DQ39603636-30F4DB4F-F1A8-407C-BD69-BF64B84BF21AQ41547084-2F7C78C8-32FF-4060-9ECF-E979A49835D3Q46857005-41112978-4167-4308-95BF-CD7219AA98A0Q47201370-F36B060D-6E89-4941-A805-38CF110E05F4Q57748981-9C7DD557-2C36-4C4E-8CE1-D90C44B23C15
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Carmen J Tartari
@en
Carmen J Tartari
@nl
type
label
Carmen J Tartari
@en
Carmen J Tartari
@nl
prefLabel
Carmen J Tartari
@en
Carmen J Tartari
@nl
P108
P31
P496
0000-0002-4576-2928